Skip to content
healthcare.dev
Get a free key

Liothyronine sodium

NDC 68382-583, Liothyronine sodium, tablet, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
68382-583
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214803
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-583 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM25 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
68382-583-0168382058301100 TABLET in 1 BOTTLE (68382-583-01)
68382-583-10683820583101000 TABLET in 1 BOTTLE (68382-583-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c54cf95f-6465-4203-b98b-a54ba5a26843

  • NADAC price for package 68382058301

    GET /v1/drugs/nadac/68382058301

Use it

Look up 68382-583 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-583 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-583. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.